Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1995
Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation
M W Dercksen, S Rodenhuis, M K Dirkson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2005
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial
A Le Cesne, J Y Blay, I Judson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2012
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy
B B Koolen, M J T F D Vrancken Peeters, J Wesseling, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 6, 2008
[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]
M E Straver, J C van Adrichem, E J Th Rutgers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2006
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer
S Rodenhuis, M Bontenbal, Q G C M van Hoesel, et al.
British Journal of Cancer
|
October 24, 2013
Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
L S Rigter, C E Loo, S C Linn, et al.
Bone Marrow Transplantation
|
July 16, 2008
Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients
P Nieboer, E G E de Vries, N H Mulder, et al.
British Journal of Cancer
|
November 8, 2006
Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy
J Hannemann, P Kristel, H van Tinteren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy
N Penel, G D Demetri, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2010
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
M A Vollebergh, E H Lips, P M Nederlof, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1995
Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation
M W Dercksen, S Rodenhuis, M K Dirkson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2005
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial
A Le Cesne, J Y Blay, I Judson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2012
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy
B B Koolen, M J T F D Vrancken Peeters, J Wesseling, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 6, 2008
[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]
M E Straver, J C van Adrichem, E J Th Rutgers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2006
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer
S Rodenhuis, M Bontenbal, Q G C M van Hoesel, et al.
British Journal of Cancer
|
October 24, 2013
Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
L S Rigter, C E Loo, S C Linn, et al.
Bone Marrow Transplantation
|
July 16, 2008
Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients
P Nieboer, E G E de Vries, N H Mulder, et al.
British Journal of Cancer
|
November 8, 2006
Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy
J Hannemann, P Kristel, H van Tinteren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy
N Penel, G D Demetri, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2010
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
M A Vollebergh, E H Lips, P M Nederlof, et al.
Page
of 15